EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Synchronous T-lymphoblastic lymphoma and neuroblastoma in a 3-yr-old with novel germline SMARCA4 and EZH2 variants

Pauline Tibout iD, Joel Livingston iD, Nisha Kanwar, Kyoko E Yuki, Adam Shlien, Bo Ngan, Meredith S Irwin, Daniel A Morgenstern iD, Johann Hitzler iD, Anita Villani, Sarah Cohen-Gogo iD

Molecular Case Studies · 2023

DOI: 10.1101/mcs.a006286 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Molecular Case Studies, 2023. Verfasst von Pauline Tibout und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario M5G 1E8, Canada. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neuroblastoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T-lymphoblastic lymphoma (T-LLy) is the most common lymphoblastic lymphoma in children and often presents with a mediastinal mass. Lymphomatous suprarenal masses are possible but rare. Here, we discuss the case of a previously healthy 3-yr-old male who presented with mediastinal T-LLy with bilateral suprarenal masses. Following initial treatment, surgical biopsy of persisting adrenal masses revealed bilateral neuroblastoma (NBL). A clinical genetics panel for germline cancer predisposition did not identify any pathogenic variants. Combination large panel (864 genes) profiling analysis in the context of a precision oncology study revealed two novel likely pathogenic heterozygous variants: SMARCA4 c.1420-1G > T p.? and EZH2 c.1943G > C p.(Ile631Phefs*44). Somatic analysis revealed potential second hits/somatic variants in EZH2 (in the T-LLy) and a segmental loss in Chromosome 19p encompassing SMARCA4 (in the NBL). Synchronous cancers, especially at a young age, warrant genetic evaluation for cancer predisposition; enrollment in a precision oncology program assessing germline and tumor DNA can fulfill that purpose, particularly when standard first-line genetic testing is negative and in the setting of tumors that are not classic for common cancer predisposition syndromes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaPrecursor T-Cell Lymphoblastic Leukemia-LymphomaNeuroblastomaChildHumansMalePrecision MedicineGenetic TestingGenetic Predisposition to DiseaseDNA HelicasesNuclear ProteinsTranscription FactorsEnhancer of Zeste Homolog 2 Protein

Stichwörter der Autor:innen

T-cell lymphoma/leukemianeuroblastoma

Substanzen

SMARCA4 protein, humanDNA HelicasesNuclear ProteinsTranscription FactorsEZH2 protein, humanEnhancer of Zeste Homolog 2 Protein

Autor:innen und Institutionen

  • Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario M5G 1E8, Canada.
  • Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario M5G 1E8, Canada.
  • Genetics and Genome Biology, The Hospital for Sick Children Research Institute, Toronto, Ontario, M5G 1E8 Canada.
  • Division of Pathology, Department of Pediatric Laboratory Medicine, Hospital for Sick Children, Toronto, Ontario M5G 1E8, Canada.
  • Department of Pediatrics, University of Toronto, Toronto, Ontario M5R 0A3, Canada.
  • Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario M5G 1E8, Canada; sarah.cohen-gogo@sickkids.ca.

ORCID-Profile: Pauline Tibout, Joel Livingston, Daniel A Morgenstern, Johann Hitzler, Sarah Cohen-Gogo

Zitieren

APA

Tibout, P., Livingston, J., Kanwar, N., Yuki, K. E., Shlien, A., Ngan, B., Irwin, M. S., Morgenstern, D. A., Hitzler, J., Villani, A., & Cohen-Gogo, S. (2023). Synchronous T-lymphoblastic lymphoma and neuroblastoma in a 3-yr-old with novel germline SMARCA4 and EZH2 variants. Molecular Case Studies. https://doi.org/10.1101/mcs.a006286

Vancouver

Tibout P, Livingston J, Kanwar N, Yuki KE, Shlien A, Ngan B, et al. Synchronous T-lymphoblastic lymphoma and neuroblastoma in a 3-yr-old with novel germline SMARCA4 and EZH2 variants. Molecular Case Studies. 2023. doi:10.1101/mcs.a006286

BibTeX
@article{Tibout2023,
  author = {Tibout, Pauline and Livingston, Joel and Kanwar, Nisha and Yuki, Kyoko E and Shlien, Adam and Ngan, Bo and Irwin, Meredith S and Morgenstern, Daniel A and Hitzler, Johann and Villani, Anita and Cohen-Gogo, Sarah},
  title = {Synchronous T-lymphoblastic lymphoma and neuroblastoma in a 3-yr-old with novel germline SMARCA4 and EZH2 variants},
  journal = {Molecular Case Studies},
  year = {2023},
  doi = {10.1101/mcs.a006286}
}
Kostenlos starten →